Schedule 13G ownership disclosure

Actinium Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 00507W107

Event date: 2019-04-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,987,012
Percent of class
8.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000080
Form type
SC 13G
Filer
Actinium Pharmaceuticals, Inc.
CIK
CIK 1388320
Filed
Apr 18, 2019
Reporting period
Apr 18, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub